Oxidation of N-methyl(R)salsolinol: Involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines

Journal of Neural Transmission, Supplement

Volumn , Issue 52, 1998, Pages 125-138

  Naoi, M ^a   Maruyama, W ^b   Kasamatsu, T ^c   Dostert, P ^d  

^a NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CYCLOHEXIMIDE; ISOQUINOLINE; SALSOLINOL; 3,4 DIHYDROXYPHENYLACETIC ACID; ANTIOXIDANT; DOPAMINE; HOMOVANILLIC ACID; HYDROXYL RADICAL; ISOQUINOLINE DERIVATIVE; NEUROTOXIN; SALSOLINE; SALSOLINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; DNA DAMAGE; DOPAMINERGIC SYSTEM; NEUROBLASTOMA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ANIMAL; BODY POSTURE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CORPUS STRIATUM; DISEASE MODEL; DRUG EFFECT; HUMAN; MALE; METABOLISM; NECROSIS; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STEREOISOMERISM; SUBSTANTIA NIGRA; SYNTHESIS; WISTAR RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTIOXIDANTS; CORPUS STRIATUM; CYCLOHEXIMIDE; DISEASE MODELS, ANIMAL; DNA DAMAGE; DOPAMINE; HOMOVANILLIC ACID; HUMANS; HYDROXYL RADICAL; ISOQUINOLINES; MALE; NECROSIS; NEUROBLASTOMA; NEURONS; NEUROTOXINS; OXIDATIVE STRESS; PARKINSON DISEASE, SECONDARY; POSTURE; RATS; RATS, WISTAR; SALSOLINE ALKALOIDS; STEREOISOMERISM; SUBSTANTIA NIGRA; TETRAHYDROISOQUINOLINES; TUMOR CELLS, CULTURED;

EID: 0031596701     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6499-0_14     Document Type: Article

References (31)

1. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquerz J, Mouatt-Prigient A, Ruberg M, Hirsch EC, Agid Y (1995) Apoptotic degeneration of nigral dopaminergic neurons in Parkinson's disease. Soci Neurosci Abstr 21: 1250
2. Bembenek ME, Abell CW, Chrisey LA, Rowadowska MD, Gessner W, Brossi A (1990) Ihhibition of monoamine oxidase A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro, 3,4-dihydro, and fully aromatic isoquinolines. J Med Chem 33: 147-152
3. +. Free Radic Biol Med 13: 581-583
4. Deng Y, Maruyama W, Dostert P, Takahashi T, Kawai M, Naoi M (1995) Determination of the (R)- and (S)-enantiomers of salsolinol and N-methylsalsolinol by use of a chiral HPLC column. J Chromatogr B 670: 47-54
5. Dipasquale B, Marini AM, Youle RJ (1991) Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Commun 181: 1442-1448
6. Dostert P, Strolin Benedetti M, Bellotti V, Allievi C, Dordain G (1990) Biosynthesis of salsolinol, a tetrahydroisoquinoline alkaloid, in healthy subjects. J Neural Transm [GenSect] 81: 215-223
7. Floyd RA, Watson JJ, Wong PK (1984) Sensitive assay of hydroxyl free radical formation utilizing high performance liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J Biochem Biophys Methods 10: 221-235
8. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AHV (1994) Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem 63: 1987-1990
9. Johnson EM Jr, Deckwerth TL (1993) Molecular mechanisms of developmental neuronal death. Ann Res Neurosci 16: 31-46
10. Maruyama W, Nakahara D, Ota M, Takahashi T, Takahashi A, Nagatsu T, Naoi M (1992) N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study. J Neurochem 59: 395-400
11. Maruyama W, Nakahara D, Dostert P, Hashiguchi H, Ohta S, Hirobe M, Takahashi A, Nagatsu T, Naoi M (1993) Selective release of serotonin by endogenous alkaloids, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, (R)- and (S)-salsolinol, in the rat striatum; in vivo microdialysis study, Neurosci Lett 149: 115-118
12. Maruyama W, Dostert P, Matsubara K, Naoi M (1995a) N-Methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity. Free Radic Biol Med 19: 67-75
13. Maruyama W, Dostert P, Naoi M (1995b) Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: In vivo and in vitro studies. J Neurochem 64: 2635-2643
14. Maruyama W, Abe T, Tohgi H, Dostert P, Naoi M (1996a) A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian CSF. Ann Neurol 40: 119-122
15. Maruyama W, Narabayashi H, Dostert P, Naoi M (1996b) Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid. J Neural Transm 103: 1069-1076
16. McNaught K, Thull U, Carrupt P-A, Altomare C, Cellamare S, Carotti A, Testa B, Kenner P, Marsden CD (1995) Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Biochem Pharmacol 50: 1903-1911
17. +) in ventral mesencephalic-striatal co-culture in rat. Neurosci Lett 170: 191-194
18. Mutoh T, Tokuda A, Marini M, Fujiki N (1994) 1-Methyl-4-phenylpyridinium kills differentiated PC12 cells with a concomitant change in protein phosphorylation. Brain Res 661: 51-55
19. Naoi M, Maruyama W, Acworth IN, Nakahara D, Parvez H (1993) Multi-electrode detection system for determination of neurotransmitters. In: Parvez H, Naoi M, Nagatsu T, Parvez S (eds) Methods in neurotransmitter and neuropeptide research, vol I. Elsevier, Amsterdam, pp 1-39
20. Naoi M, Maruyama W, Dostert P (1995a) Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines: oxidation and neurotoxicity. Prog Brain Res 106: 227-239
21. Naoi M, Maruyama W, Zhang JH, Takahashi T, Deng Y, Dostert P (1995b) Enzymatic oxidation of the dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion. Life Sci 57: 1061-1066
22. Naoi M, Maruyama W, Dostert P, Hashizume Y, Takahashi T, Ota M (1996a) Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rats: biochemical, pathological and behavioral studies. Brain Res 709: 285-295
23. Naoi M, Maruyama W, Dostert P, Hashizume Y (1996b) Animal model of Parkinson's disease induced by naturally-occurring 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline. Biogen Amines 12: 135-147
24. Origitano T, Hanningen J, Collins MA (1981) Rat brain salsolinol and blood-brain barrier. Brain Res 224: 446-451
25. Östling O, Johanson KJ (1984) Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 123: 291-298
26. Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GD, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515-520
27. Sällström Baum S, Rommelspacher H (1994) Determination of total dopamine, R- and S-salsolinol in human plasma by cyclodextrin bonded-phase liquid chromatography with electrochemical detection. J Chromatogr B 660: 235-241
28. Singh NP, McCoy MT, Tice RR, Schneider EL (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175: 184-191
29. Stanley F, Gerald C (1992) The oxidative stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32: 804-812
30. Strolin Benedetti M, Bellotti V, Pianezola E, Moro E, Carminati P, Dostert P (1989) Ratio of the R and S enantiomers of salsolinol in food and human urine. J Neural Transm 77: 47-53
31. Teitel S, O'Brien J, Brossi A (1972) Alkaloids in mammalian tissue. II. Synthesis of (+) and (-) substituted-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines. J Med Chem 15: 845-846